| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0009 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |